苏子降气汤联合西药治疗慢性阻塞性肺疾病急性加重期临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R563

基金项目:


Clinical Study on Suzi Jiangqi Decoction Combined with Western Medicine for Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察慢性阻塞性肺疾病急性加重期应用苏子降气汤联合西药治疗的临床疗效及其对炎性反 应的影响。方法:将收治的88 例慢性阻塞性肺疾病急性加重期患者分为2 组各44 例。对照组予常规西药治 疗。观察组在对照组治疗方案的基础上加用苏子降气汤治疗。观察2 组中医证候评分(胸膈满闷、咳痰、咳 嗽、纳呆、喘息、哮鸣音)、中医证候临床疗效、肺功能[呼气峰值流速(PEF)、第1 秒用力呼气容 积(FEV1)、用力肺活量(FVC) 以及FEV1/FVC]、血气分析[动脉血氧分压(PaO2)、动脉血氧饱和 度(SaO2)、动脉血二氧化碳分压(PaCO2)],以及血清超敏C-反应蛋白(hs-CRP)、白细胞介素-6(IL-6)、 降钙素原(PCT)、D 二聚体(D-D) 等。结果:治疗后,观察组中医证候各项评分均低于对照组,差异均有统 计学意义(P<0.05);中医证候临床疗效总有效率观察组95.45%,对照组79.55%,2 组比较,差异有统计学 意义(P<0.05)。观察组PEF、FEV1、FVC、FEV1/FVC、PaO2、SaO2 均高于对照组,观察组PaCO2 低于对照 组,差异均有统计学意义(P<0.05);观察组hs-CRP、IL-6、PCT、D-D 水平均低于对照组,差异均有统计 学意义(P<0.05)。结论:苏子降气汤联合西药治疗慢性阻塞性肺疾病急性加重期,可缓解多种临床症状并改 善肺功能,降低炎性因子,提高临床疗效。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Suzi Jiangqi Decoction combined with western medicine on acute exacerbation of chronic obstructive pulmonary disease and its effects on inflammatory responses. Methods: A total of 88 patients with acute exacerbation of chronic obstructive pulmonary disease were divided into two groups,with 44 cases in each group. The control group was given routine western medicine,and the observation group was additionally treated with Suzi Jiangqi Decoction based on the treatment of the control group. The traditional Chinese medicine(TCM) syndrome scores, including thoracic diaphragm distension and discomfort, expectoration, cough, torpid intake, wheezing and wheezing rales, clinical effects on TCM syndromes, indexes of lung function, including peak expiratory flow (PEF), forced expiratory volume in one second (FEV1), forced vital capacity (FVC) and FEV1/FVC, indexes of blood gas analysis, including partial pressure of oxygen in arterial- blood (PaO2), oxygen saturation (SaO2) and partial pressure of carbon dioxide (PaCO2), as well as the levels of serum highsensitivity C- reactive protein (hs- CRP),interleukin- 6 (IL- 6),procalcitonin (PCT) and D- Dimer (D- D) in both groups were observed. Results: After treatment, the TCM syndrome scores of each item in the observation group were lower than those in the control group,differences being significant (P<0.05);the total effective rate of TCM syndromes was 95.45% in the observation group,higher than that of 79.55% in the control group,the difference being significant (P<0.05). The PEF,FEV1,FVC,FEV1/FVC,PaO2 and SaO2 in the observation group were higher than those in the control group,and the PaCO2 was lower than that in the control group,differences being significant (P<0.05);the levels of hs-CRP,IL-6,PCT and D-D in the observation group were lower than those in the control group,differences being significant (P< 0.05). Conclusion: Suzi Jiangqi Decoction combined with western medicine for acute exacerbation of chronic obstructive pulmonary disease can mitigate various clinical symptoms,improve the lung function, decrease the levels of inflammatory factors,and enhance the clinical effect.

    参考文献
    相似文献
    引证文献
引用本文

戴乐凤.苏子降气汤联合西药治疗慢性阻塞性肺疾病急性加重期临床研究[J].新中医,2023,55(6):6-10

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-03-28
  • 出版日期: